The Federal Trade Commission said it is seeking to block Amgen’s $27.8 billion acquisition of Horizon Therapeutics, in a rare effort by antitrust enforcers to prevent a merger of pharmaceutical companies. The FTC on Tuesday filed a lawsuit in federal court seeking an injunction that would prevent …